Factors Affecting Participation in Daily Living in Stroke: Roles of Spasticity, Upper Extremity, Cognition and Function
1 other identifier
observational
49
1 country
1
Brief Summary
The aim of this study is to identify the factors affecting participation in daily living activities in stroke individuals and their interrelationships. Participation in daily living activities and related factors such as spasticity, upper extremity function, cognitive status, and functional status were assessed in individuals diagnosed with stroke. Hypothesis 1: Spasticity in stroke patients affects participation in daily living activities. Hypothesis 2: Upper extremity function in stroke patients affects participation in daily living activities. Hypothesis 3: Cognitive status in stroke patients affects participation in daily living activities. Hypothesis 4: Functional status in stroke patients affects participation in daily living activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedFirst Submitted
Initial submission to the registry
July 16, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedJuly 23, 2026
July 1, 2026
1.6 years
July 16, 2026
July 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stroke Impact Scale (SIS) for assessment of participation in activities of daily living.
The current SIS 3.0 is a revised version of the original SIS developed by Duncan et al. SIS 3.0 includes 59 items measuring eight domains, including strength, hand function, activities of daily living/instrumental activities of daily living, mobility, communication, emotion, memory/thinking, and participation, and one item assessing overall improvement. Items are rated using a Guttman-type scale with five response options. Patients are expected to complete the scale based on the difficulties they perceived last week. Scores of 5, 4, 3, 2, and 1 correspond to the options "not difficult at all," "very little difficult," "somewhat difficult," "very difficult," and "extremely difficult," respectively. Turkish validity and reliability were established by Hantal et al. in 2014, with Cronbachα values \> 0.70 and ICC 0.947 (0.947-0.999).
The assessment was performed at least 3 months after the stroke.
Secondary Outcomes (10)
Muscle tone assessment using the Modified Ashworth Scale (MAS).
The assessment was performed at least 3 months after the stroke.
Nine Hole Peg Test (NHPT) Assessment of upper extremity function
The assessment was performed at least 3 months after the stroke.
Assessment of upper extremity dexterity with Dexterity Questionnaire-24 (DextQ-24)
The assessment was performed at least 3 months after the stroke.
Montreal Cognitive Assessment (MoCA) for cognitive status assessment.
The assessment was performed at least 3 months after the stroke.
Fatigue assessment using the Fatigue Severity Scale (FSS).
The assessment was performed at least 3 months after the stroke.
- +5 more secondary outcomes
Study Arms (1)
Individuals with Stroke
Eligibility Criteria
Individuals aged 18-80 diagnosed with stroke who were examined at the neurology outpatient clinic of Pamukkale University Hospitals.
You may qualify if:
- Having a stroke diagnosis.
- At least 3 months must have passed since the stroke.
- Not having hearing, vision, or speech problems that would affect the tests.
- Agreeing to participate in the study.
- Not having any non-stroke neurological or orthopedic disease that could affect function.
You may not qualify if:
- Having undergone musculoskeletal surgery on the upper extremity.
- Less than 3 months having passed since the stroke.
- Having hearing, vision, or speech problems severe enough to affect the tests.
- Having any non-stroke neurological or orthopedic disease that may affect function.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pamukkale University
Denizli, 20070, Turkey (Türkiye)
Related Publications (11)
Lin KC, Fu T, Wu CY, Hsieh YW, Chen CL, Lee PC. Psychometric comparisons of the Stroke Impact Scale 3.0 and Stroke-Specific Quality of Life Scale. Qual Life Res. 2010 Apr;19(3):435-43. doi: 10.1007/s11136-010-9597-5. Epub 2010 Feb 4.
PMID: 20127418BACKGROUNDDuncan PW, Bode RK, Min Lai S, Perera S; Glycine Antagonist in Neuroprotection Americans Investigators. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003 Jul;84(7):950-63. doi: 10.1016/s0003-9993(03)00035-2.
PMID: 12881816BACKGROUNDDönmez S., Dağ H., Kazandı M., Amniyosentez Öncesi Gebelerde Anksiyete ve Depresyon Risk Düzeylerinin Belirlenmesi. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi. 2012;4(3):255-259.
BACKGROUNDCharlson ME, Pompei P, Ales KL, MacKenzie CR. A newmethod of classifyingprognosticcomorbidity in longitudinalstudies: developmentandvalidation. J ChronicDis 1987;40:373-83.
BACKGROUNDYalın H., İnme Sonrası Hastaların Fonksiyonel Durum, Engellilik Ve Yaşam Kaliteleri. Marmara Üniversitesi Sağlık Bilimleri Enstitüsü. İstanbul. 2011:42-43
BACKGROUNDGencay-Can A, Can SS. Validation of theTurkishversion of thefatigueseverityscale in patientswithfibromyalgia. RheumatolInt. 2012;32(1):27- 31.
BACKGROUNDKrupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121-3. doi: 10.1001/archneur.1989.00520460115022.
PMID: 2803071BACKGROUNDÇebi M. Mental durum için Kısa Test(STMS) ve MoCA'nınMMSE'ye karşı normal-Alzheimer Hastalığı-Hafif Kognitif Bozukluk Spektrumunda ayrım yeteneğinin karşılaştırılması. Yüksek lisans Tezi, İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü, İstanbul, 2012:23
BACKGROUNDVanbellingen T, Nyffeler T, Nef T, Kwakkel G, Bohlhalter S, van Wegen EE. Reliability and validity of a new dexterity questionnaire (DextQ-24) in Parkinson's disease. Parkinsonism Relat Disord. 2016 Dec;33:78-83. doi: 10.1016/j.parkreldis.2016.09.015. Epub 2016 Sep 15.
PMID: 27663063BACKGROUNDErhan B, Gündüz B. Spastisite. Tıbbi rehabilitasyon. 3. Baskı. İstanbul:Nobel Tıp Kitapevleri. 2015:565-573
BACKGROUNDMathiowetz V, Weber K, Kashman N et al. Adultnormsfor nine hole peg test of fingerdexterity. TheOccupTher J. Res. 1983;5(1):25-38.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nilüfer ÇETİŞLİ KORKMAZ, PT.PhD.Prof.
Pamukkale University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist, MSc
Study Record Dates
First Submitted
July 16, 2026
First Posted
July 23, 2026
Study Start
September 5, 2020
Primary Completion
April 30, 2022
Study Completion
April 30, 2022
Last Updated
July 23, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. The dataset contains sensitive clinical information obtained from individuals who have experienced a stroke. Due to ethical considerations, participant confidentiality, and institutional requirements regarding the protection of personal health information, individual-level data sharing is not planned.